Pacritinib With Aza for Upfront Myelodysplastic Syndrome

NCT07387354 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndromes
MDS
Myelodysplastic Syndrome, Unclassifiable
Hematologic Diseases
Bone Marrow Disease
Myeloproliferative Neoplasm

Interventions

DRUG: Pacritinib
DRUG: Azacitidine
PROCEDURE: Bone Marrow Biopsy and Aspirate
DIAGNOSTIC_TEST: Laboratory Testing
DIAGNOSTIC_TEST: Electrocardiogram
OTHER: Quality of Life in Myelodysplasia Scale

Sponsor

Thomas Jefferson University

Collaborators

[object Object]